Today’s Free Research Report Coverage on Evolent Health and Three More Healthcare Information Services Stocks

Stock Research Monitor: ATHN, HQY, and TDOC

LONDON, UK / ACCESSWIRE / May 18, 2018 / If you want a free Stock Review on EVH sign up now at www.wallstequities.com/registration. Today's research on WallStEquities.com is focused on athenahealth Inc. (NASDAQ: ATHN), Evolent Health Inc. (NYSE: EVH), HealthEquity Inc. (NASDAQ: HQY), and Teladoc Inc. (NYSE: TDOC). Companies in the Healthcare Information Services industry manage the information that health care professionals need to perform their job effectively and efficiently. They automate administrative, financial, and patient-care activities of hospitals, produce extensive management reports, operational statistics, and provide a powerful query module. All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

athenahealth

On Thursday, shares in Watertown, Massachusetts headquartered athenahealth Inc. recorded a trading volume of 288,005 shares. The stock ended the session 0.57% higher at $149.43. The Company's shares have gained 1.63% in the last month, 5.80% over the previous three months, and 40.60% over the past year. The stock is trading 5.12% above its 50-day moving average and 11.22% above its 200-day moving average. Moreover, shares of athenahealth, which together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems, have a Relative Strength Index (RSI) of 58.38.

On April 26th, 2018, athenahealth announced its results for Q1 FY18. Total revenue for the three months ended March 31st, 2018 was $329.4 million, GAAP gross margin was 53.2%, and GAAP operating income was $42.1 million. GAAP net income for Q1 2018 was $31.1 million, and total bookings were $52.2 million.

On May 15th, 2018, research firm Berenberg downgraded the Company's stock rating from 'Buy' to 'Hold'. Get the full research report on ATHN for free by clicking below at:

www.wallstequities.com/registration/?symbol=ATHN

Evolent Health

Arlington, Virginia headquartered Evolent Health Inc.'s stock closed the day flat at $19.65 with a total trading volume of 817,432 shares. The Company's shares have advanced 19.45% in the past month and 37.89% in the previous three months. The stock is trading 24.12% and 27.39% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Evolent Health, which through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the US, have an RSI of 82.87.

On April 24th, 2018, research firm JP Morgan resumed its 'Neutral' rating on the Company's stock, with a target price of $17 per share.

On May 14th, 2018, Evolent Health announced that CFO, Nicky McGrane, will present at the Jefferies 2018 Global Healthcare Conference on June 05th, 2018, at 9:00 a.m. EST in New York. Additionally, Mr. McGrane and CEO & Co-Founder, Frank Williams, will present at the William Blair 38th Annual Growth Stock Conference on June 12th, 2018, at 7:30 a.m. CST in Chicago. Free research on EVH can be accessed at:

www.wallstequities.com/registration/?symbol=EVH

HealthEquity

Shares in Draper, Utah headquartered HealthEquity Inc. recorded a trading volume of 388,256 shares. The stock ended yesterday's trading session 0.77% higher at $72.24. The Company's shares have advanced 9.31% in the past month, 32.04% in the previous three months, and 63.07% over the past year. The stock is trading above its 50-day and 200-day moving averages by 11.90% and 36.78%, respectively. Furthermore, shares of HealthEquity, which provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the US, have an RSI of 71.27.

On April 24th, 2018, research firm JP Morgan resumed its 'Overweight' rating on the Company's stock, with a target price of $69 per share.

On May 14th, 2018, HealthEquity announced plans to release its Q1 FY19 financial results, following the close of regular stock market trading hours on June 04th, 2018. Following the news release, Management plans to host a conference call for investors at 5:00 p.m. ET that day to review highlights from the Company's results. Visit WallStEquities.com now and sign up for the free research on HQY at:

www.wallstequities.com/registration/?symbol=HQY

Teladoc

Purchase, New York headquartered Teladoc Inc.'s stock finished Thursday's session 1.52% lower at $48.70 with a total trading volume of 767,772 shares. The Company's shares have advanced 14.19% in the last month, 31.98% over the previous three months, and 76.77% over the past year. The stock is trading above its 50-day and 200-day moving averages by 14.06% and 35.56%, respectively. Additionally, shares of Teladoc, which provides telehealth services worldwide, have an RSI of 65.19.

On April 25th, 2018, Teladoc announced the US launch of Behavioral Health Navigator, bringing innovation to virtual care delivery and the diagnosis and treatment of behavioral health conditions. Behavioral Health Navigator is an integrated care service that provides specialized "navigation," support, and coordination, combined with virtual access to expert providers for those facing mental health conditions. The free technical report on TDOC is available at:

www.wallstequities.com/registration/?symbol=TDOC

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com

Phone number: 21 32 044 483

Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities